Vivoryon Therapeutics N.V. new ISIN code

Vivoryon Therapeutics N.V. new Home Member State
Vivoryon Therapeutics N.V. Announces Nominations to Reappoint Ulrich Dauer as CEO and to Appoint Florian Schmid as CFO